Same Indication

Lorazepam vs Nivolumab

Lorazepam vs Nivolumab: Overview

This comparison examines the pharmacological differences between Lorazepam and Nivolumab.

Mechanism of Action

Lorazepam: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Lorazepam — 10-20 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Lorazepam — C15H10Cl2N2O2.

Molecular Weight: Lorazepam — 321.1580 g/mol.

Type: Lorazepam — Small molecule; Nivolumab — Antibody.